CARE

National Medical Care Co.

4005StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	4.49B	6.38B	7.46B	7.82B	3.31B
Market Cap Growth	-32.0%	-14.6%	-4.6%	+136.0%	+18.1%
Enterprise Value	4.71B	6.43B	7.51B	7.21B	3.27B
Last Close Price	100.40	138.91	160.59	165.78	69.67
Valuation Multiples
Forward PE (Next 12M Est.)	13.42	17.86	23.45	29.16	20.89
PE Ratio	15.72	20.03	25.33	32.47	19.49
PEG Ratio	—	1.26	1.51	1.48	2.04
PS Ratio	2.80	3.99	5.77	7.23	3.61
PB Ratio	2.36	3.45	4.59	5.38	2.62
P/TBV Ratio	2.55	3.75	5.05	5.84	2.63
P/FCF Ratio	—	237.96	54.62	18.95	17.84
P/OCF Ratio	—	41.42	30.51	16.76	15.28
EV/Sales Ratio	2.94	4.02	5.81	6.67	3.56
EV/EBITDA Ratio	10.89	14.69	23.85	24.79	13.66
EV/EBIT Ratio	14.71	18.13	29.93	29.24	16.56
EV/FCF Ratio	-25.02	239.90	55.00	17.48	17.58
Leverage & Capital
Debt / Equity Ratio	0.28	0.28	0.30	0.23	0.07
Debt / EBITDA Ratio	1.11	1.11	1.46	1.11	0.35
Debt / FCF Ratio	19.26	19.26	3.57	0.80	0.45
Net Debt / Equity Ratio	-0.01	-0.01	-0.05	-0.25	-0.20
Net Debt / EBITDA Ratio	-0.03	-0.03	-0.25	-1.25	-1.03
Net Debt / FCF Ratio	-0.54	-0.54	-0.58	-0.88	-1.32
Efficiency & Liquidity
Asset Turnover	0.61	0.61	0.55	0.55	0.56
Inventory Turnover	16.71	16.71	15.34	14.95	14.26
Quick Ratio	3.93	3.93	3.29	3.45	3.47
Current Ratio	4.30	4.30	3.53	3.68	3.69
Returns & Yields
Return on Equity (ROE)	+18.3%	+18.3%	+19.1%	+17.7%	+14.2%
Return on Assets (ROA)	+8.4%	+8.4%	+6.7%	+7.9%	+7.5%
Return on Invested Capital (ROIC)	+17.7%	+19.3%	+19.0%	+21.3%	+18.2%
Return on Capital Employed (ROCE)	+14.6%	+14.6%	+11.7%	+13.2%	+13.8%
Earnings Yield	+6.4%	+5.0%	+3.9%	+3.1%	+5.1%
FCF Yield	-4.2%	+0.4%	+1.8%	+5.3%	+5.6%
Dividend Yield	+2.9%	+2.2%	+1.2%	+1.2%	+1.4%
Payout Ratio	+31.3%	+28.1%	+30.4%	+18.6%	+26.4%
Buyback Yield / Dilution	+0.2%	+0.2%	+0.2%	—	—
Total Shareholder Return	+3.1%	+2.3%	+1.4%	+1.2%	+1.4%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	4.49B	6.38B	7.46B	7.82B	3.31B
Market Cap Growth	-32.0%	-14.6%	-4.6%	+136.0%	+18.1%
Enterprise Value	4.71B	6.43B	7.51B	7.21B	3.27B
Last Close Price	100.40	138.91	160.59	165.78	69.67
Valuation Multiples
Forward PE (Next 12M Est.)	13.42	17.86	23.45	29.16	20.89
PE Ratio	15.72	20.03	25.33	32.47	19.49
PEG Ratio	—	1.26	1.51	1.48	2.04
PS Ratio	2.80	3.99	5.77	7.23	3.61
PB Ratio	2.36	3.45	4.59	5.38	2.62
P/TBV Ratio	2.55	3.75	5.05	5.84	2.63
P/FCF Ratio	—	237.96	54.62	18.95	17.84
P/OCF Ratio	—	41.42	30.51	16.76	15.28
EV/Sales Ratio	2.94	4.02	5.81	6.67	3.56
EV/EBITDA Ratio	10.89	14.69	23.85	24.79	13.66
EV/EBIT Ratio	14.71	18.13	29.93	29.24	16.56
EV/FCF Ratio	-25.02	239.90	55.00	17.48	17.58
Leverage & Capital
Debt / Equity Ratio	0.28	0.28	0.30	0.23	0.07
Debt / EBITDA Ratio	1.11	1.11	1.46	1.11	0.35
Debt / FCF Ratio	19.26	19.26	3.57	0.80	0.45
Net Debt / Equity Ratio	-0.01	-0.01	-0.05	-0.25	-0.20
Net Debt / EBITDA Ratio	-0.03	-0.03	-0.25	-1.25	-1.03
Net Debt / FCF Ratio	-0.54	-0.54	-0.58	-0.88	-1.32
Efficiency & Liquidity
Asset Turnover	0.61	0.61	0.55	0.55	0.56
Inventory Turnover	16.71	16.71	15.34	14.95	14.26
Quick Ratio	3.93	3.93	3.29	3.45	3.47
Current Ratio	4.30	4.30	3.53	3.68	3.69
Returns & Yields
Return on Equity (ROE)	+18.3%	+18.3%	+19.1%	+17.7%	+14.2%
Return on Assets (ROA)	+8.4%	+8.4%	+6.7%	+7.9%	+7.5%
Return on Invested Capital (ROIC)	+17.7%	+19.3%	+19.0%	+21.3%	+18.2%
Return on Capital Employed (ROCE)	+14.6%	+14.6%	+11.7%	+13.2%	+13.8%
Earnings Yield	+6.4%	+5.0%	+3.9%	+3.1%	+5.1%
FCF Yield	-4.2%	+0.4%	+1.8%	+5.3%	+5.6%
Dividend Yield	+2.9%	+2.2%	+1.2%	+1.2%	+1.4%
Payout Ratio	+31.3%	+28.1%	+30.4%	+18.6%	+26.4%
Buyback Yield / Dilution	+0.2%	+0.2%	+0.2%	—	—
Total Shareholder Return	+3.1%	+2.3%	+1.4%	+1.2%	+1.4%